GI Dynamics Inc
GI Dynamics Announces Additional Members to Its Scientific Advisory Board
GI Dynamics® Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier® in Europe, the Middle East and South America for patients with type 2 diabetes and obesity announced additional members of the GI Dynamics Scientific Advisory Board (SAB), bringing...
GI Dynamics Inc
GI Dynamics Announces EndoBarrier Data to be Presented at Digestive Disease Week
Digestive Disease Week® (DDW), taking place May 6 – 9, 2017 in Chicago, Illinois GI Dynamics®, Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier® in Europe, the Middle East and South America for patients with type...
